NEOGENOMICS INC — Director's Dealing 2021

Dec 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-30

Reporting Person: Gilbert Halley E (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-30	Common Stock	A	45858	—	Acquired	105086	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock	$42.21	2028-08-17	Common Stock (63331.0)	63331	Direct

Footnotes

F1: On December 30, 2021, Ms. Gilbert was granted 45,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.

F2: On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.